Located in Hengqin, Guangdong Province, Guangdong-Macao Deep Cooperation Zone, Zhuhai Medifa Biotechnology Co., Ltd. was founded by several Austrian returnee PhD's. The founding shareholders responsible for the company's operation and management have long experience in management and innovation of multinational corporations, and the core technology team consists of the world's top research and development talents. Adopting cutting-edge synthetic biology engineering technology, Medifa focuses on the independent innovation and development of new-generation all-bio-based naturally degradable PHA biomaterials and their downstream high-end derivatives for large-scale production, application and marketization. Since its establishment in early 2019, the company has made an all-round layout in terms of intellectual property rights, and has realized patent coverage of the whole industrial chain of new PHA materials from strains, fermentation process, purification, application development, etc.